__timestamp | Alnylam Pharmaceuticals, Inc. | Perrigo Company plc |
---|---|---|
Wednesday, January 1, 2014 | 50561000 | 1447700000 |
Thursday, January 1, 2015 | 41097000 | 1712400000 |
Friday, January 1, 2016 | 47159000 | 2051800000 |
Sunday, January 1, 2017 | 76545000 | 1979500000 |
Monday, January 1, 2018 | 73106000 | 1831500000 |
Tuesday, January 1, 2019 | 194688000 | 1773300000 |
Wednesday, January 1, 2020 | 414801000 | 1815200000 |
Friday, January 1, 2021 | 704143000 | 1416200000 |
Saturday, January 1, 2022 | 868601000 | 1455400000 |
Sunday, January 1, 2023 | 1517886000 | 1680400000 |
Monday, January 1, 2024 | 1924873000 |
In pursuit of knowledge
In the ever-evolving landscape of the pharmaceutical industry, Alnylam Pharmaceuticals, Inc. and Perrigo Company plc have showcased intriguing trends in their gross profit margins over the past decade. From 2014 to 2023, Alnylam Pharmaceuticals has experienced a remarkable growth trajectory, with its gross profit surging by over 2,900%, reaching approximately $1.52 billion in 2023. This growth reflects Alnylam's strategic advancements in RNA interference therapeutics.
Conversely, Perrigo Company, a stalwart in the over-the-counter healthcare sector, has maintained a steady gross profit, peaking at around $2.05 billion in 2016. Despite a slight decline, Perrigo's gross profit remains robust, highlighting its resilience in a competitive market. This comparison underscores the dynamic nature of the pharmaceutical industry, where innovation and market adaptation are key to sustained success.
Who Generates Higher Gross Profit? Amgen Inc. or Perrigo Company plc
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Grifols, S.A. and Perrigo Company plc: A Detailed Gross Profit Analysis
Perrigo Company plc vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Perrigo Company plc and BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Perrigo Company plc vs MiMedx Group, Inc.